Corona Remedies Ltd vs Vaishali Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Corona Remedies Ltd is ₹ 1580 as of 19 Feb 10:41 . The P/E Ratio of Corona Remedies Ltd is 0 as of March 2023 .The P/E Ratio of Vaishali Pharma Ltd is 0 as of March 2023 . The Market Cap of Corona Remedies Ltd is ₹ 0 crore as of March 2023 .The Market Cap of Vaishali Pharma Ltd is ₹ 0 crore as of March 2023 . The revenue of Corona Remedies Ltd for the Mar '25 is ₹ 295.32 crore as compare to the Dec '25 revenue of ₹ 344.68 crore. This represent the decline of -14.32% The revenue of Vaishali Pharma Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 25.54 crore. This represent the decline of -100% The ebitda of Corona Remedies Ltd for the Mar '25 is ₹ 55.85 crore as compare to the Dec '25 ebitda of ₹ 66.32 crore. This represent the decline of -15.79% The ebitda of Vaishali Pharma Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 2.45 crore. This represent the decline of -100% The net profit of Corona Remedies Ltd changed from ₹ 29.95 crore to ₹ 31.55 crore over 7 quarters. This represents a CAGR of 3.02% The net profit of Vaishali Pharma Ltd changed from ₹ 1.28 crore to ₹ 0 crore over 4 quarters. This represents a CAGR of -100.00% The Dividend Payout of Corona Remedies Ltd changed from 20 % on March 2023 to 30 % on March 2025 . This represents a CAGR of 14.47% over 3 yearsThe Dividend Payout of Vaishali Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Corona Remedies Ltd

Corona Remedies Limited was originally incorporated as CORONA Remedies Private Limited', a private limited company, dated August 27, 2004, issued by the Assistant Registrar of Companies, Gujarat at Dadra and Nagar Haveli.
Thereafter, Company converted into a public limited and Company name has changed to CORONA Remedies Limited'.
A fresh certificate of incorporation, is issued by the Registrar of Companies, Central Processing Centre, Manesar, Haryana on December 16, 2024. The manufacturing facilities of the Company are located at Solan (Himachal Pradesh) and at Bhayla (Ahmedabad, Gujarat).
The Company is engaged in manufacturing, trading and marketing of Pharmaceutical products in women's healthcare, cardio-diabeto, pain management, urology and other therapeutic areas. In 2004, Company launched the first division, and later named it as Pioneer' division in year 2010; launched Xemx (multispeciality) division in 2005.

About Vaishali Pharma Ltd

Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name 'Vaishali Pharma Private Limited' on 25th, April 2008.
On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz.
M/s.
Vaishali Pharmachem through Business Assignment agreement.
Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited.

FAQs for the comparison of Corona Remedies Ltd and Vaishali Pharma Ltd

Which company has a larger market capitalization, Corona Remedies Ltd or Vaishali Pharma Ltd?

Market cap of Corona Remedies Ltd is 10,588 Cr while Market cap of Vaishali Pharma Ltd is 96 Cr

What are the key factors driving the stock performance of Corona Remedies Ltd and Vaishali Pharma Ltd?

The stock performance of Corona Remedies Ltd and Vaishali Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Corona Remedies Ltd and Vaishali Pharma Ltd?

As of May 5, 2026, the Corona Remedies Ltd stock price is INR ₹1731.2. On the other hand, Vaishali Pharma Ltd stock price is INR ₹7.43.

How do dividend payouts of Corona Remedies Ltd and Vaishali Pharma Ltd compare?

To compare the dividend payouts of Corona Remedies Ltd and Vaishali Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.